| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated cisplatin-based chemotherapy for advanced bladder cancer
|
Boshoff, C.
|
|
1995
|
31 |
10 |
p. 1633-1636
4 p.
|
artikel
|
| 2 |
A cost analysis of Nd:YAG Laser ablation versus endoscopic intubation for the palliation of malignant dysphagia
|
Sculpher, M.J.
|
|
1995
|
31 |
10 |
p. 1640-1646
7 p.
|
artikel
|
| 3 |
Active specific immunotherapy with an autologous virus-modified tumour cell vaccine in human renal cell carcinoma (RCC)
|
Hinkel, A.
|
|
1995
|
31 |
10 |
p. 1719-1720
2 p.
|
artikel
|
| 4 |
Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro
|
Hanauske, A.-R.
|
|
1995
|
31 |
10 |
p. 1677-1681
5 p.
|
artikel
|
| 5 |
Adult cancer risks among the mothers of children with cancer
|
Gustafsson, B.
|
|
1995
|
31 |
10 |
p. 1653-1655
3 p.
|
artikel
|
| 6 |
A European view of ASCO-95
|
Alberto, P.
|
|
1995
|
31 |
10 |
p. 1592-1593
2 p.
|
artikel
|
| 7 |
A message from the editor
|
Senn, Hans-Jörg
|
|
1995
|
31 |
10 |
p. 1555-
1 p.
|
artikel
|
| 8 |
A prospective randomised study in limited disease small cell carcinoma—Doxorubicin and vincristine plus either cyclophosphamide or etoposide
|
Abratt, R.P.
|
|
1995
|
31 |
10 |
p. 1637-1639
3 p.
|
artikel
|
| 9 |
A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer
|
Parnis, F.X.
|
|
1995
|
31 |
10 |
p. 1721-
1 p.
|
artikel
|
| 10 |
Assessment of five serum marker assays in patients with advanced breast cancer treated with medroxyprogesterone acetate
|
Murray, A.
|
|
1995
|
31 |
10 |
p. 1605-1610
6 p.
|
artikel
|
| 11 |
Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients
|
Veronesi, U.
|
|
1995
|
31 |
10 |
p. 1574-1579
6 p.
|
artikel
|
| 12 |
Cancer surveys volume 24: Cell adhesion and cancer
|
Hart, I.
|
|
1995
|
31 |
10 |
p. 1712-1713
2 p.
|
artikel
|
| 13 |
CEA, MCA, CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative study
|
Martoni, A.
|
|
1995
|
31 |
10 |
p. 1615-1621
7 p.
|
artikel
|
| 14 |
Clinical stage B non-seminomatous germ cell testis cancer: The Indiana University experience (1965–1989) using routine primary retroperitoneal lymph node dissection
|
Donohue, J.P.
|
|
1995
|
31 |
10 |
p. 1599-1604
6 p.
|
artikel
|
| 15 |
Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for prophylactic treatment of emesis induced by cisplatin chemotherapy
|
Tsukuda, M.
|
|
1995
|
31 |
10 |
p. 1647-1649
3 p.
|
artikel
|
| 16 |
Diverging trends in colorectal cancer morbidity and mortality. Earlier diagnosis comes at a price
|
Bonneux, L.
|
|
1995
|
31 |
10 |
p. 1665-1671
7 p.
|
artikel
|
| 17 |
Eicosanoids and radiation
|
Milas, L.
|
|
1995
|
31 |
10 |
p. 1580-1585
6 p.
|
artikel
|
| 18 |
Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours
|
Ellis, P.A.
|
|
1995
|
31 |
10 |
p. 1594-1598
5 p.
|
artikel
|
| 19 |
Evaluation of the informed consent procedure in cancer patients candidate to immunotherapy
|
Négrier, S.
|
|
1995
|
31 |
10 |
p. 1650-1652
3 p.
|
artikel
|
| 20 |
Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123
|
Koizumi, S.
|
|
1995
|
31 |
10 |
p. 1682-1688
7 p.
|
artikel
|
| 21 |
Haemopoietic stem cell inhibition: Potential for dose intensification
|
Marshall, E.
|
|
1995
|
31 |
10 |
p. 1586-1591
6 p.
|
artikel
|
| 22 |
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group
|
Brausi, M.
|
|
1995
|
31 |
10 |
p. 1622-1626
5 p.
|
artikel
|
| 23 |
High dose 5-fluorouracil (5-FU) and folinic acid in advanced colorectal cancer resistant to standard dose 5-FU treatment: Results of a phase II study
|
Jäger, E.
|
|
1995
|
31 |
10 |
p. 1717-
1 p.
|
artikel
|
| 24 |
Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer
|
Pantel, K.
|
|
1995
|
31 |
10 |
p. 1627-1632
6 p.
|
artikel
|
| 25 |
International cancer news
|
Tagnon, Henri
|
|
1995
|
31 |
10 |
p. 1556-1561
6 p.
|
artikel
|
| 26 |
Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer
|
Lopez, M.
|
|
1995
|
31 |
10 |
p. 1611-1614
4 p.
|
artikel
|
| 27 |
Lumpectomy versus quadrantectomy for breast conservation: a critical appraisal
|
Fisher, B.
|
|
1995
|
31 |
10 |
p. 1567-1569
3 p.
|
artikel
|
| 28 |
Ondansetron for the control of dacarbazine-induced emesis
|
Campora, E.
|
|
1995
|
31 |
10 |
p. 1720-1721
2 p.
|
artikel
|
| 29 |
Patterns of DNA methylation of the parathyroid hormone-related protein gene in human lung carcinoma
|
Ganderton, R.H.
|
|
1995
|
31 |
10 |
p. 1697-1700
4 p.
|
artikel
|
| 30 |
Persisting elevation of alphafetoprotein after chemotherapy for germ cell tumour—not always due to viable malignancy?
|
Shannon, J.A.
|
|
1995
|
31 |
10 |
p. 1722-
1 p.
|
artikel
|
| 31 |
Postmastectomy radiotherapy, axillary lymph node dissection and oestrogen receptor status predict prognosis
|
Norum, J.
|
|
1995
|
31 |
10 |
p. 1714-
1 p.
|
artikel
|
| 32 |
Prognostic significance of Lewis X related antigen expression in stage I non-small cell lung cancer
|
Ogawa, J-i.
|
|
1995
|
31 |
10 |
p. 1716-
1 p.
|
artikel
|
| 33 |
Prognostic value of CD44 splice variants in human stage III cervical cancer
|
Kainz, C.
|
|
1995
|
31 |
10 |
p. 1706-1709
4 p.
|
artikel
|
| 34 |
Prostate cancer—What should be studied?
|
James, N.D.
|
|
1995
|
31 |
10 |
p. 1565-1566
2 p.
|
artikel
|
| 35 |
Repeating the avidin “chase” markedly improved the biodistribution of radiolabelled biotinylated antibodies and promoted the excretion of additional background radioactivity
|
Kobayashi, H.
|
|
1995
|
31 |
10 |
p. 1689-1696
8 p.
|
artikel
|
| 36 |
Ribonucleotide reductase inhibition in the treatment of advanced prostate cancer: an experimental approach with hydroxyurea and gallium nitrate in 20 patients
|
Santarossa, S.
|
|
1995
|
31 |
10 |
p. 1718-
1 p.
|
artikel
|
| 37 |
Risk analysis in acute lymphoblastic leukaemia: Problems and pitfalls
|
Chessells, J.M.
|
|
1995
|
31 |
10 |
p. 1656-1659
4 p.
|
artikel
|
| 38 |
Routine or delayed axillary dissection for primary breast cancer?
|
Epstein, R.J.
|
|
1995
|
31 |
10 |
p. 1570-1573
4 p.
|
artikel
|
| 39 |
Socioeconomic status and breast cancer survival in the southeastern Netherlands, 1980–1989
|
Schrijvers, C.T.M.
|
|
1995
|
31 |
10 |
p. 1660-1664
5 p.
|
artikel
|
| 40 |
Spreading evaluation in primitive bronchogenic carcinoma: Benefit of cerebral MRI compared to CT scan
|
Lemiere, C.
|
|
1995
|
31 |
10 |
p. 1715-
1 p.
|
artikel
|
| 41 |
The effect of different dose levels of degradable starch microspheres (Spherex®) on the distribution of a cytotoxic drug after regional administration to tumour-bearing rats
|
Teder, H.
|
|
1995
|
31 |
10 |
p. 1701-1705
5 p.
|
artikel
|
| 42 |
The management of cervical intra-epithelial neoplasia (CIN): Extensiveness and costs in The Netherlands
|
van Ballegooijen, M.
|
|
1995
|
31 |
10 |
p. 1672-1676
5 p.
|
artikel
|
| 43 |
The performance of a commercial radioligand binding assay for the epidermal growth factor receptor is comparable to the EORTC standard assay
|
Oberkanins, C.
|
|
1995
|
31 |
10 |
p. 1710-1711
2 p.
|
artikel
|
| 44 |
Why can't we cure primary liver cancer?
|
Johnson, P.J.
|
|
1995
|
31 |
10 |
p. 1562-1564
3 p.
|
artikel
|
Tijdschrift beschrijving